Safran MR, Foard SJ, Robell K, Pullen WM. Incidence of Symptomatic Femoroacetabular Impingement: A 4-Year Study at a National Collegiate Athletic Association Division I Institution.
Orthop J Sports Med 2022;
10:23259671221084979. [PMID:
35434170 PMCID:
PMC9008859 DOI:
10.1177/23259671221084979]
[Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/01/2021] [Accepted: 12/15/2021] [Indexed: 11/17/2022] Open
Abstract
Background:
Femoroacetabular impingement (FAI) is an increasingly recognized
cause of hip pain in young athletes. Although there are multiple
studies that describe the radiographic prevalence of FAI in
athletes, its true incidence within this population is
unknown.
Purpose:
To report on the overall and sport-specific incidence of
symptomatic FAI in National Collegiate Athletic Association
(NCAA) Division I athletes. Return-to-sport times were reported
for patients treated operatively.
Study Design:
Cohort study; Level of evidence, 3.
Methods:
A retrospective review was conducted to identify all reported hip
injuries within a large, multisport NCAA Division I institution.
Hip injuries were stratified into FAI, general pain/dysfunction,
musculotendinous, ligament, bursitis, bone stress, contusion,
and other. FAI was diagnosed based on history, physical
examinations, imaging, and symptomatic relief after a diagnostic
injection. Descriptive statistics were used to calculate the
overall and sport-specific incidence, and chi-square analysis
was performed to identify contingency data.
Results:
In a 3-year period, a total of 5319 musculoskeletal injuries
occurred in 1072 athletes. There were 491 (9.2%) hip injuries
that occurred in 288 athletes, of which 40 injuries were FAI.
The overall incidence of symptomatic FAI was 3.0% of the total
population, 3.7% of all injured athletes, and 13.9% of athletic
hip injuries. There were no statistically significant
differences in FAI rates among male and female athletes overall
or among male and female athletes within similar sports. Of the
19 athletes who were treated nonoperatively, 2 failed to return
to play: 1 secondary to multiple musculoskeletal injuries and 1
related to cardiac issues. There were 21 hips in 20 patients
that were treated operatively, with 1 athlete failing to return
to sport. Return to play occurred at a mean of 202 days (range,
81-360 days) after hip arthroscopic surgery.
Conclusion:
In this large, multisport NCAA Division I cohort, the overall
incidence of symptomatic FAI was 3.0% and represented 13.9% of
hip injuries. The successful management of FAI with return to
play was achieved by both nonoperative and operative treatment
methods. The relatively low incidence of symptomatic FAI,
despite reports of a high prevalence of FAI morphology in
athletes, serves to emphasize the importance of clinical
evaluations in treating patients with FAI.
Collapse